Kazuhiro Yoneda

Has grant

Osaka University
Country flagJapan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Open

人工知能を用いた救急・集中治療患者の客観的な痛みモニタリングシステムの確立

Open Date: 2024-04-01

Close Date: 2027-03-31

Grant: Open

慢性期外傷性脳損傷はなぜ起きるのか -爆傷による軽症頭部外傷の病態を明らかにする-

Open Date: 2024-04-01

Close Date: 2027-03-31

Grant: Close

免疫応答バランスからみた熱傷後の免疫不全メカニズムに関する統合的解析

Open Date: 2023-04-01

Close Date: 2026-03-31

Articles (8)

Acute iron poisoning is rare but potentially fatal. Deferoxamine (DFO) is the standard chelating agent and the appearance of “vin‐rose urine” has traditionally been considered a marker of effective chelation; however, its relationship with serum iron concentration over time remains unclear. A 17‐year‐old female patient presented with abdominal pain and acute liver dysfunction 43 h after intentional ingestion of sodium ferrous citrate (approximately 40 mg/kg of elemental iron). Continuous intravenous DFO was administered at a dose of 100 mg/kg for approximately 6 h. The urine color changed to vin‐rose within 1 h and normalized 12 h after DFO initiation. Despite the normalization of urine color, abdominal pain persisted. Serial laboratory analyses showed that serum iron levels transiently decreased, but then increased repeatedly, even after the normalization of urine color. This case provides chronological documentation of urine color changes alongside serial measurements of serum iron and ferritin, illustrating that the normalization of urine color does not necessarily indicate the normalization of serum iron levels. Urine color changes may need to be interpreted in conjunction with multiple clinical factors, clinical symptoms, and laboratory findings of acute iron poisoning.

Year:

2026

Year:

2026

Year:

2026

Burn management in patients requiring pelvic external fixation is extremely challenging due to restricted positioning and difficulty maintaining airtight negative pressure wound therapy (NPWT). Practical techniques to secure NPWT in this setting are rarely described. A 53-year-old man sustained 26% TBSA deep burns and an unstable pelvic fracture treated with external fixation. Circumferential trunk eschar excision was achieved by alternating lateral positions, as prone positioning was not feasible. Negative pressure wound therapy was applied for wound bed preparation and graft fixation. Airtight sealing was obtained using stoma paste around fixation pins and a belt-like silver-containing dressing on raw surfaces, reinforced with stoma paste to create a stable adhesion ridge. These methods enabled sustained negative pressure and stable graft take without regrafting. (1) Safe circumferential debridement achieved by alternating lateral positions. (2) Stoma paste effectively sealed difficult contours. (3) Silver dressing under stoma paste created an antimicrobial, sealable ridge for film adhesion. (4) “Double-sided film sealing” around pins maintained airtight NPWT. This case highlights practical NPWT sealing strategies enabling safe burn care under pelvic external fixation.

Year:

2025

This single-center retrospective observational study was conducted to investigate whether soluble T-cadherin reflects endothelial injury and predicts fluid requirements in burn patients. The study population included 64 adult patients with ≥20% total body surface area burns who were admitted to Japan Community Health Care Organization Chukyo Hospital Burn Center (Nagoya, Japan) between 2014 and 2019, as well as 16 healthy individuals as controls. Serum levels of soluble T-cadherin (130 kDa and 100 kDa isoforms) and adiponectin were measured at two phases: Phase 1 (days 1–2) and Phase 2 (days 7–12). Compared to healthy controls, burn patients had significantly lower levels of 100 kDa and 130 kDa soluble T-cadherin (p < 0.05). In Phase 1, 100 kDa T-cadherin was negatively correlated with 24-h fluid requirement (p = 0.01) and PAI-1 levels (an endothelial injury marker). Multivariate regression identified 100 kDa T-cadherin as the sole independent predictor of fluid requirement (estimate: -0.04, p = 0.01). Syndecan-1 was also inversely correlated with 130 kDa T-cadherin. Adiponectin levels in patients and controls did not differ to a statistically significant extent. This is the first study to report reduced circulating levels of soluble T-cadherin in burn patients and its inverse relationship with early fluid resuscitation volume. These findings suggest that 100 kDa T-cadherin may serve as a novel biomarker for endothelial injury and guide individualized fluid management in burn care.

Year:

2025

Aim When treating burn patients, some patients die in the chronic phase, even if they overcome the acute phase of the burn. To elucidate the timing of death and its underlying causes among burn patients. Methods Patients evaluated were admitted to our burn center between January 2015, and December 2019. Patient information, time, and cause of death were retrospectively collected from their medical records. Results Among 342 admitted patients, 49 died. The time of death was as follows: within 24 h ( n = 9), within 3 days ( n = 7), within 1 week ( n = 5), within 2 weeks ( n = 4), within 3 weeks ( n = 3), within 30 days ( n = 6), within 60 days ( n = 5), and after 60 days ( n = 9). The causes of death within 3 days were hypoxic encephalopathy, extensive burns (>80%), severe heat stroke, and acute coronary syndrome. The causes of death after 3 days were sepsis, pneumonia, intestinal ischemia, pancreatitis, and worsening of chronic diseases. The mortality rate was similar for patients ≥65 years of age and those with a burn area of ≥20%, with both groups showing a particularly poor prognosis. Conclusions The timing of death in hospitalized burn patients showed a bimodal distribution as approximately 40% of patients who survived the resuscitation period died after 30 days. Elderly patients were at particularly high risk for mortality. In burn care, treatment planning should consider not only the short‐term but also the long‐term prognosis.

Year:

2024

Record-breaking heat waves over the past 20 years have led to a global increase in heat-related deaths, including heatstroke. Heat-related illnesses occur when the body cannot adapt to the elevated temperatures in the environment, leading to various symptoms. In severe situations, such as heatstroke, the body temperature can rise above 40°C, leading to significant injury to body systems, with particular susceptibility of the central nervous system (CNS). Neuroimaging studies conducted months or years after a heatstroke have revealed cellular damage in the cerebellum and other brain regions, including the hippocampus, midbrain, and thalamus, with the potential for long-term neurological complications in survivors of a heatstroke. This mini review aimed to describe the mechanisms and pathways underlying the development of brain injury induced by heatstroke and identify diagnostic imaging tools and biomarkers for injury to the CNS due to a heatstroke.

Year:

2024

Immune responses that occur following burn injury comprise a series of reactions that are activated in response to damaged autologous tissues, followed by removal of damaged tissues and foreign pathogens such as invading bacteria, and tissue repair. These immune responses are considered to be programmed in living organisms. Developments of modern medicine have led to the saving of burned patients who could not be cured previously; however, the programmed response is no longer able to keep up, and various problems have arisen. This paper describes the mechanism of immune response specific to burn injury and the emerging concept of persistent inflammation, immunosuppression, and catabolism syndrome.

Year:

2024

Collaborators (6)

Yusuke Katayama

Assistant Professor

Osaka University

JAPAN
View details

Jun Oda

-

JAPAN
View details

Hiroshi Ito

Osaka University

JAPAN
View details

Shunichiro Nakao

SA Assistant Professor

Osaka University Hospital

JAPAN
View details

Shunbun Kita

Associate Professor

Osaka University

JAPAN
View details

Jotaro Tachino

Osaka University Graduate School of Medicine

JAPAN
View details